Definitive Contract HT942524C0067

Award Date 8/12/24
Potential Completion Date 12/11/26
Potential Value $1.3M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawndale, CA 90260, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,300,000.00 Firm Fixed Price definitive contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, for the SBIR Phase II effort titled "Succor Combat Foam for Large Burn Wounds". The contract supports research and development of a specialized foam solution for treating large burn wounds, which is a critical capability for the military. Critical Innovations has been awarded over $10 million in previous prime federal contracts across...
This is a $250,000.00 Firm Fixed Price purchase order awarded to Critical Innovations LLC, a small business, by the Defense Health Agency (DHA) under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of the "Succor Combat Foam for Open Traumatic Brain Injury Medical R&D" topic. This SBIR award is a total small business set-aside, indicating Critical Innovations is the prime contractor without any major subcontractors. The...
This is a $1,550,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company. The contract is for the Small Business Innovation Research (SBIR) Phase II project "DHA SBIR PHASE II O2-1681" and has a completion date of December 3, 2021. The contract is designated as a total small business set-aside. Critical Innovations, an ISO 13485:2016 certified medical research and development company,...
The U.S. Army's Joint PEO Chemical and Biological Defense has awarded a $1,099,999.92 Firm Fixed Price contract to Critical Innovations LLC, a small business medical research and development company, for Phase II of a Small Business Innovation Research (SBIR) program effort. The contract is designated as a total small business set-aside. Critical Innovations will continue development of various advanced medical technologies for military and pre-hospital applications, including solutions for...
This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control". Critical Innovations is an ISO certified and DCAA compliant medical research and development company that has been awarded over $10...
This is a $150,000.00 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business located in Lawndale, California. The contract is for a Small Business Innovation Research (SBIR) Phase I effort, which is a research and development task focused on innovative solutions for military and pre-hospital healthcare applications. The contract has a period of performance ending on April 24, 2018 and is designated as a total small...
The Department of the Army awarded a $167,499.96 firm-fixed-price Phase I Small Business Innovation Research (SBIR) program contract to Critical Innovations LLC, a limited liability company, for research and development efforts to develop treatments for dermal injuries caused by sulfur mustard. The contract has a total small business set-aside designation. Critical Innovations has previously received over $10 million in SBIR contracts from the Army, Defense Health Agency, and Air Force for...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a $946,809.00 Firm Fixed Price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a for-profit limited liability company. The contract is for the Pleurapath Chest Tube Augmentation and Acceleration Program under the Joint Warfighter Medical Research Program, which is a SBIR Phase III action with no set-aside designation. Critical Innovations LLC is an ISO certified, DCAA compliant medical R&D company that has received over $10...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Medical Command (MEDCOM) of the Defense Health Agency (DHA) to Critical Innovations LLC, a small business LLC. The $1,100,000.00 contract is for the development of the "RX-Shooter Wearable Wound Infection Treatment Device" under Topic DHA213-009. The award is designated as a total small business set-aside. Critical Innovations is an ISO 13485:2016 certified medical research and development company that...

This is a $1,300,000.00 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company, for the development of the Succor Combat Foam for advanced wound care of traumatized tissue. The contract is part of the Small Business Innovation Research (SBIR) Program Phase II, with an ultimate completion date of December 11, 2026. The contract is designated as a total small business set-aside. Critical Innovations LLC is the prime contractor and has established itself as a provider of innovative medical technologies to defense agencies, including projects related to wound treatment, hemorrhage control, and automated diagnosis and treatment systems.

Generated 11/4/24, 10:28 AM